Literature DB >> 22453915

Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia: continuity from carrier status to smoldering ATL.

Shimeru Kamihira1, Masako Iwanaga, Yuko Doi, Daisuke Sasaki, Sayaka Mori, Kazuto Tsurda, Kazuhiro Nagai, Naoki Uno, Hiroo Hasegawa, Katsunori Yanagihara, Yoshitomo Morinaga, Kunihiro Tsukasaki, Hiroaki Taniguchi.   

Abstract

To better understand indeterminate HTLV-1 carriers and smoldering (SM) subtype of adult T-cell leukemia (ATL), HTLV-1 proviral integrated status, proviral load (PVL) and ATL-related biomarkers were examined in 57 smoldering cases, including unusual carriers with a percentage of ATL-like cells. We found that according to Southern blot hybridization analytic features, 28 patients with SM ATL could be divided into 3 groups consisting of 16 (57.4%) patients with a monoclonal band, 6 (21.4%) with oligoclonal bands and the remaining 6 with smears. Although no clinical differences were observed among the 3 SM subtypes, HTLV-1-infected CD4 T-cell counts increased in order of poly-, oligo- and monoclonal subtypes. This trend began in the carrier stage and also was observed in PVL, CD25 and CCR4, indicating that a clone consisting of leukemic phenotypic cells was continuously growing. Moreover, the antigen modulation rates of CD26 and CD7 and the increasing rate of CD25 and CCR4 cells were closely correlated to growing clonal size, indicating that these markers had the possibility to predict a monoclonal band. In particular, CD26 or the ratio of CD26/CD25 had a validity differential for leukemic nature and predictive detection of clonal band. Conclusively, the present study shows that smoldering ATL is heterogeneous in the leukemogenic process, and the behavior of CD26 plays a central role in the evolution from early occult to overt smoldering ATL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453915     DOI: 10.1007/s12185-012-1020-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  21 in total

1.  An ATL cell line with an IgH pseudo-rearranged band pattern by southern blotting: a pitfall of genetic diagnosis.

Authors:  Akiko Uemura; Kazuyuki Sugahara; Hiroshi Nagai; Kenn Murata; Hiroo Hasegawa; Yoichi Hirakata; Kunihiro Tsukasaki; Yasuaki Yamada; Shimeru Kamihira
Journal:  Lab Hematol       Date:  2005

2.  Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count.

Authors:  S Kamihira; N Dateki; K Sugahara; T Hayashi; H Harasawa; S Minami; Y Hirakata; Y Yamada
Journal:  Clin Lab Haematol       Date:  2003-04

3.  Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

Authors:  Maria Grazia Narducci; Enrico Scala; Antonella Bresin; Elisabetta Caprini; Maria Cristina Picchio; Daniele Remotti; Gianluca Ragone; Francesca Nasorri; Marina Frontani; Diego Arcelli; Stefano Volinia; Giuseppe Alfonso Lombardo; Giannandrea Baliva; Monica Napolitano; Giandomenico Russo
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

4.  Proviral status of HTLV-1 integrated into the host genomic DNA of adult T-cell leukemia cells.

Authors:  S Kamihira; K Sugahara; K Tsuruda; S Minami; A Uemura; N Akamatsu; H Nagai; K Murata; H Hasegawa; Y Hirakata; Y Takasaki; K Tsukasaki; Y Yamada
Journal:  Clin Lab Haematol       Date:  2005-08

5.  Chromosomal imbalances in adult T-cell leukemia revealed by comparative genomic hybridization: gains at 14q32 and 2p16-22 in cell lines.

Authors:  Y Ariyama; T Mori; T Shinomiya; T Sakabe; Y Fukuda; A Kanamaru; Y Yamada; M Isobe; M Seto; Y Nakamura; J Inazawa
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

6.  Real-time polymerase chain reaction for quantification of HTLV-1 proviral load: application for analyzing aberrant integration of the proviral DNA in adult T-cell leukemia.

Authors:  S Kamihira; N Dateki; K Sugahara; Y Yamada; M Tomonaga; T Maeda; M Tahara
Journal:  Int J Hematol       Date:  2000-07       Impact factor: 2.490

Review 7.  [Southern blot hybridization analysis for lymphoid neoplasms].

Authors:  K Sugahara; Y Yamada
Journal:  Rinsho Byori       Date:  2000-08

8.  CD26 regulates p38 mitogen-activated protein kinase-dependent phosphorylation of integrin beta1, adhesion to extracellular matrix, and tumorigenicity of T-anaplastic large cell lymphoma Karpas 299.

Authors:  Tsutomu Sato; Tadanori Yamochi; Toshiko Yamochi; Ugur Aytac; Kei Ohnuma; Kathryn S McKee; Chikao Morimoto; Nam H Dang
Journal:  Cancer Res       Date:  2005-08-01       Impact factor: 12.701

9.  High human T cell leukemia virus type-1(HTLV-1) provirus load in patients with HTLV-1 carriers complicated with HTLV-1-unrelated disorders.

Authors:  Daisuke Sasaki; Yuko Doi; Hiroo Hasegawa; Katsunori Yanagihara; Kunihiro Tsukasaki; Masako Iwanaga; Yasuaki Yamada; Toshiki Watanabe; Shimeru Kamihira
Journal:  Virol J       Date:  2010-04-28       Impact factor: 4.099

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  10 in total

1.  HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.

Authors:  Noriaki Kitamura; Tsukasa Nakanishi; Yasuhiro Yoshida; Takehiro Higashi; Junichi Tsukada
Journal:  Blood       Date:  2017-05-09       Impact factor: 22.113

2.  Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia.

Authors:  Sanaz Firouzi; Amir Farmanbar; Kenta Nakai; Masako Iwanaga; Kaoru Uchimaru; Atae Utsunomiya; Yutaka Suzuki; Toshiki Watanabe
Journal:  Blood Adv       Date:  2017-06-27

3.  Transition of adult T-cell leukemia/lymphoma clones during clinical progression.

Authors:  Sakura Aoki; Sanaz Firouzi; Yosvany López; Tadanori Yamochi; Kazumi Nakano; Kaoru Uchimaru; Atae Utusnomiya; Masako Iwanaga; Toshiki Watanabe
Journal:  Int J Hematol       Date:  2016-07-06       Impact factor: 2.490

4.  Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.

Authors:  Hikaru Sakamoto; Hidehiro Itonaga; Yasushi Sawayama; Azusa Kojima; Masahiko Chiwata; Machiko Fujioka; Hiroko Kitanosono; Makiko Horai; Teiichiro Miyazaki; Hirokazu Shiraishi; Yoshitaka Imaizumi; Shinichiro Yoshida; Tomoko Hata; Yoshihisa Yamano; Yasushi Miyazaki
Journal:  Int J Hematol       Date:  2021-01-10       Impact factor: 2.490

5.  Simian T-lymphotropic Virus-associated lymphoma in 2 naturally infected baboons: T-cell clonal expansion and immune response during tumor development.

Authors:  Jean M d'Offay; Richard Eberle; Roman F Wolf; Stanley D Kosanke; Kelly R Doocy; Sahlu Ayalew; Keith G Mansfeild; Gary L White
Journal:  Comp Med       Date:  2013-06       Impact factor: 0.982

6.  Adult T-cell leukemia: a review of epidemiological evidence.

Authors:  Masako Iwanaga; Toshiki Watanabe; Kazunari Yamaguchi
Journal:  Front Microbiol       Date:  2012-09-10       Impact factor: 5.640

7.  Advanced human T-cell leukemia virus type 1 carriers and early-stage indolent adult T-cell leukemia-lymphoma are indistinguishable based on CADM1 positivity in flow cytometry.

Authors:  Seiichiro Kobayashi; Eri Watanabe; Tomohiro Ishigaki; Nobuhiro Ohno; Koichiro Yuji; Kazumi Nakano; Tadanori Yamochi; Nobukazu Watanabe; Arinobu Tojo; Toshiki Watanabe; Kaoru Uchimaru
Journal:  Cancer Sci       Date:  2015-03-20       Impact factor: 6.716

8.  Development and validation of a new high-throughput method to investigate the clonality of HTLV-1-infected cells based on provirus integration sites.

Authors:  Sanaz Firouzi; Yosvany López; Yutaka Suzuki; Kenta Nakai; Sumio Sugano; Tadanori Yamochi; Toshiki Watanabe
Journal:  Genome Med       Date:  2014-06-27       Impact factor: 11.117

9.  Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.

Authors:  Huseini H Kagdi; Maria A Demontis; Paul A Fields; Juan Carlos Ramos; Charles R M Bangham; Graham P Taylor
Journal:  Cancer Med       Date:  2016-12-30       Impact factor: 4.452

10.  Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.

Authors:  Huseini Kagdi; Maria Antonietta Demontis; Juan Carlos Ramos; Graham P Taylor
Journal:  PLoS Pathog       Date:  2018-02-14       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.